Form 4 for LSTA LISATA THERAPEUTICS, INC.
Accepted 2026-01-13 00:00:00 ET · period of report 2026-01-09 · accession 0001309653-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-13 | 2026-01-09 | LSTA | AZAB MOHAMMAD | Dir | A - Grant | $0.00 | +30.5K | 104.9K | +41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-09 | A | A | 30,456 | $0.00 | 104,925 | D | — | — | (F1) Represents 30,456 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2027. (F2) Includes 30,456 unvested restricted stock units. |